Yang Pan, Dan Wang & Fan Liu. (2022) miR-146b suppresses LPS-induced M1 macrophage polarization via inhibiting the FGL2-activated NF-κB/MAPK signaling pathway in inflammatory bowel disease. Clinics 77, pages 100069.
Crossref
Björn Nüse & Jochen Mattner. (2021) L-arginine as a novel target for clinical intervention in inflammatory bowel disease. Exploration of Immunology.
Crossref
Sayan Malakar. 2020. Clinical Significance of C-reactive Protein. Clinical Significance of C-reactive Protein
59
93
.
Fernando Magro, Paolo Gionchetti, Rami Eliakim, Sandro Ardizzone, Alessandro Armuzzi, Manuel Barreiro-de Acosta, Johan Burisch, Krisztina B. Gecse, Ailsa L. Hart, Pieter Hindryckx, Cord Langner, Jimmy K. Limdi, Gianluca Pellino, Edyta Zagórowicz, Tim Raine, Marcus Harbord & Florian Rieder. (2017) Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. Journal of Crohn's and Colitis 11:6, pages 649-670.
Crossref
Francesco Manguso, Raffaele Bennato, Giovanni Lombardi, Elisabetta Riccio, Giuseppe Costantino & Walter Fries. (2016) Efficacy and Safety of Oral Beclomethasone Dipropionate in Ulcerative Colitis: A Systematic Review and Meta-Analysis. PLOS ONE 11:11, pages e0166455.
Crossref
Roberta Pica, Claudio Cassieri, Andrea Cocco, Maddalena Zippi, Adriana Marcheggiano, Daniela De Nitto, Eleonora Veronica Avallone, Pietro Crispino, Giuseppe Occhigrossi & Paolo Paoluzi. (2015) A randomized trial comparing 4.8 vs. 2.4g/day of oral mesalazine for maintenance of remission in ulcerative colitis. Digestive and Liver Disease 47:11, pages 933-937.
Crossref
Avegail Flores, Ezra Burstein, Daisha J. Cipher & Linda A. Feagins. (2015) Obesity in Inflammatory Bowel Disease: A Marker of Less Severe Disease. Digestive Diseases and Sciences 60:8, pages 2436-2445.
Crossref
A. Dignass, R. Eliakim, F. Magro, C. Maaser, Y. Chowers, K. Geboes, G. Mantzaris, W. Reinisch, J.-F. Colombel, S. Vermeire, S. Travis, J.O. Lindsay & G. van Assche. (2014) Segundo Consenso Europeo basado en evidencia sobre el diagnóstico y tratamiento de la colitis ulcerosa crónica idiopática Parte 1: Definiciones y diagnóstico (versión española). Revista de Gastroenterología de México 79:4, pages 263-289.
Crossref
Soo-Kyung Park, Byong Duk Ye, Suk-Kyun Yang, Seon-Ok Kim, Jihun Kim, Jong Wook Kim, Sang Hyoung Park, Dong-Hoon Yang, Kee Wook Jung, Kyung-Jo Kim, Jeong-Sik Byeon, Seung-Jae Myung & Jin-Ho Kim. (2014) Clinical features and course of ulcerative colitis diagnosed in asymptomatic subjects. Journal of Crohn's and Colitis 8:10, pages 1254-1260.
Crossref
Annette L. Hartzell, María X. Maldonado-Gómez, Junyi Yang, Robert W. Hutkins & Devin J. Rose. (2013) In vitro digestion and fermentation of 5-formyl-aminosailcylate-inulin: A potential prodrug of 5-aminosalicylic acid. Bioactive Carbohydrates and Dietary Fibre 2:1, pages 8-14.
Crossref
Ioannis E KoutroubakisEdward BarnesHans Herfarth. 2013. Advances in the Management of Inflammatory Bowel Disease. Advances in the Management of Inflammatory Bowel Disease
50
66
.
Axel Dignass, Rami Eliakim, Fernando Magro, Christian Maaser, Yehuda Chowers, Karel Geboes, Gerassimos Mantzaris, Walter Reinisch, Jean-Frederic Colombel, Severine Vermeire, Simon Travis, James O. Lindsay & Gert Van Assche. (2012) Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis. Journal of Crohn's and Colitis 6:10, pages 965-990.
Crossref
Devin J. Rose. 2011. Advances in Cereal Science: Implications to Food Processing and Health Promotion. Advances in Cereal Science: Implications to Food Processing and Health Promotion
111
130
.
Leonidas A. Bourikas & Konstantinos A. Papadakis. 2010. Inflammatory Bowel Disease. Inflammatory Bowel Disease
195
211
.
Mark T. Osterman & Gary R. Lichtenstein. 2010. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease
1975
2013.e9
.
G. R. LICHTENSTEIN & M. A. KAMM. (2008) Review article: 5-aminosalicylate formulations for the treatment of ulcerative colitis - methods of comparing release rates and delivery of 5-aminosalicylate to the colonic mucosa. Alimentary Pharmacology & Therapeutics 28:6, pages 663-673.
Crossref
E.F. Stange, S.P.L. Travis, S. Vermeire, W. Reinisch, K. Geboes, A. Barakauskiene, R. Feakins, J.F. Fléjou, H. Herfarth, D.W. Hommes, L. Kupcinskas, P.L. Lakatos, G.J. Mantzaris, S. Schreiber, V. Villanacci & B.F. Warren. (2008) European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis. Journal of Crohn's and Colitis 2:1, pages 1-23.
Crossref
Andreas Holstein, Eick-Hartwig Egberts & Axel Von Herbay. (2006) Rheumatoid-like nodules in the spleen: New extraintestinal manifestation of Crohn’s disease?. Journal of Gastroenterology and Hepatology 21:1, pages 295-298.
Crossref
Oliver Schroder, Oliver Mickisch, Ursula Seidler, Andreas de Weerth, Axel U. Dignass, Hans Herfarth, Max Reinshagen, Stefan Schreiber, Ulrich Junge, Marc Schrott & Jurgen Stein. (2005) Intravenous Iron Sucrose versus Oral Iron Supplementation for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease-A Randomized, Controlled, Open-Label, Multicenter Study. The American Journal of Gastroenterology 100:11, pages 2503-2509.
Crossref
Nathalie Huyghebaert, An Vermeire & Jean Paul Remon. (2005) In vitro evaluation of coating polymers for enteric coating and human ileal targeting. International Journal of Pharmaceutics 298:1, pages 26-37.
Crossref
Els Mehuys, Jean-Paul Remon & Chris Vervaet. (2005) Production of enteric capsules by means of hot-melt extrusion. European Journal of Pharmaceutical Sciences 24:2-3, pages 207-212.
Crossref
David R. Friend. (2005) New oral delivery systems for treatment of inflammatory bowel disease. Advanced Drug Delivery Reviews 57:2, pages 247-265.
Crossref
Remo Panaccione & Lloyd R. Sutherland. 2005. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
269
290
.
Remo Panaccione & Lloyd R. Sutherland. 2003. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
269
290
.
Konstantinos A. Papadakis & Maria T. Abreu. 2003. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
235
250
.
Konstantinos A. Papadakis & Maria T. Abreu. 2005. Inflammatory Bowel Disease: From Bench to Bedside. Inflammatory Bowel Disease: From Bench to Bedside
235
250
.
Konstantinos A Papadakis & Siamak Tabibzadeh. (2002) Diagnosis and misdiagnosis of inflammatory bowel disease. Gastrointestinal Endoscopy Clinics of North America 12:3, pages 433-449.
Crossref
C. Beglinger, L. Degen, M. von Flüe, F. Harder, W. Langewitz, W. R. Marti, D. Oertli & M. Zuber. 2002. Praxis der Viszeralchirurgie. Praxis der Viszeralchirurgie
495
556
.
Toyohiro Sakata, Yasumasa Niwa, Hidemi Goto, Yoshiki Hirooka, Tetsuo Hayakawa, Naoki Ohmiya & Seibi Kobayashi. (2001) Asymptomatic inflammatory bowel disease with special reference to ulcerative colitis in apparently healthy persons. The American Journal of Gastroenterology 96:3, pages 735-739.
Crossref
Chinyu Su, Gary R Lichtenstein & Gary R. Lichtenstein. (2000) Diagnosis of Crohn's Disease: A Wolf in Sheep's Clothing?. American Journal of Gastroenterology 95:12, pages 3345-3350.
Crossref
M.I. Vera Mendoza, J. Fernández García, N. Fernández Puga & L. Abreu García. (2000) Colitis ulcerosa. Medicine - Programa de Formación Médica Continuada Acreditado 8:6, pages 283-287.
Crossref
Peter D. Han, Anne Burke, Robert N. Baldassano, John L. Rombeau & Gary R. Lichtenstein. (1999) NUTRITION AND INFLAMMATORY BOWEL DISEASE. Gastroenterology Clinics of North America 28:2, pages 423-443.
Crossref
K. Geboes & A. Jouret. (1999) Aspects macroscopiques et microscopiques des maladies inflammatoires coliques chroniques idiopathiques (MICI)Macroscopy and microscopy of chronic idiopathic inflammatory bowel diseases (IBD). Acta Endoscopica 29:3, pages 175-188.
Crossref
Maureen O'Reilly Brown. (1999) INFLAMMATORY BOWEL DISEASE. Primary Care: Clinics in Office Practice 26:1, pages 141-170.
Crossref
Rolland Parc, Vianney Roger & Christophe Penna. 1999. Operative Strategies in Inflammatory Bowel Disease. Operative Strategies in Inflammatory Bowel Disease
229
233
.
Heiko C. Rath, Tilo Andus, Inka Caesar & Jürgen Schölmerich. (1998) Erstsymptome, extraintestinale Manifestationen und Schwangerschaftsverlauf bei chronisch entzündlichen DarmerkrankungenInitial symptoms, extraintestinal manifestations and course of pregnancy in 392 patients with inflammatory bowel disease. Coloproctology 20:6, pages 214-221.
Crossref
Friend. (2001) Review article: issues in oral administration of locally acting glucocorticosteroids for treatment of inflammatory bowel disease. Alimentary Pharmacology & Therapeutics 12:7, pages 591-603.
Crossref
Heiko C. Rath, Tilo Andus, Inka Caesar & Jürgen Schölmerich. (1998) Erstsymptome, extraintestinale Manifestationen und Schwangerschaftsverlauf bei chronisch entzündlichen DarmerkrankungenInitial symptoms, extraintestinal manifestations and course of pregnancy in 392 patients with inflammatory bowel disease. Medizinische Klinik 93:7, pages 395-400.
Crossref
Marie L. Borum. (1998) GASTROINTESTINAL DISEASES IN WOMEN. Medical Clinics of North America 82:1, pages 21-50.
Crossref
David E. Deutsch & Allan D. Olson. (1997) Colonoscopy or Sigmoidoscopy as the Initial Evaluation of Pediatric Patients with Colitis: A Survey of Physician Behavior and a Cost Analysis. Journal of Pediatric Gastroenterology & Nutrition 25:1, pages 26-31.
Crossref
JOHN E. SMITHSON, BRYAN F. WARREN, SUSAN YOUNG, ROD PIGOTT & DEREK P. JEWELL. (1996) HETEROGENEOUS EXPRESSION OF CARCINOEMBRYONIC ANTIGEN IN THE NORMAL COLON AND UPREGULATION IN ACTIVE ULCERATIVE COLITIS. The Journal of Pathology 180:2, pages 146-151.
Crossref
E V Tsianos, C N Masalas, M Merkouropoulos, G N Dalekos & R F Logan. (1994) Incidence of inflammatory bowel disease in north west Greece: rarity of Crohn's disease in an area where ulcerative colitis is common.. Gut 35:3, pages 369-372.
Crossref
S. Björck, A. Dahlström, L. Johansson & H. Ahlman. (1992) Treatment of the mucosa with local anaesthetics in ulcerative colitis. Agents and Actions 36:3-4, pages C60-C72.
Crossref
S. Björck, A. Dahlström, L. Johansson & H. Ahlman. (1992) Treatment of the mucosa with local anaesthetics in ulcerative colitis. Agents and Actions 36:S1, pages C60-C72.
Crossref
M. VILIEN, M. J. JØRGENSEN, Q. OUYANG, P. SCHLICHTING, J. LINDE, P. RIIS & V. BINDER. (1991) Colonic epithelial dysplasia or carcinoma in a regional group of patients with ulcerative colitis of more than 15 years duration. Journal of Internal Medicine 230:3, pages 259-263.
Crossref
Marianne OrholmPia MunkholmEbbe LangholzOle Haagen NielsenThorkild I.A. SørensenVibeke Binder. (1991) Familial Occurrence of Inflammatory Bowel Disease. New England Journal of Medicine 324:2, pages 84-88.
Crossref
L. D. Juby, D. E. Long, M. F. Dixon & A. T. R. Axon. (1990) Prognostic indicators and clinical course in proctosigmoiditis. International Journal of Colorectal Disease 5:4, pages 177-180.
Crossref
John H. Robert, David B. Sachar, Arthur H. AufsesJrJr & Adrian J. Greenstein. (1990) Management of severe hemorrhage in ulcerative colitis. The American Journal of Surgery 159:6, pages 550-555.
Crossref
Lloyd R. Sutherland. (1990) Topical Treatment of Ulcerative Colitis. Medical Clinics of North America 74:1, pages 119-131.
Crossref
Richard G. Farmer. (1990) Evolution of the Concept of Proctosigmoiditis: Clinical Observation. Medical Clinics of North America 74:1, pages 91-102.
Crossref
Richard G. Farmer. (1987) Nonspecific Ulcerative Proctitis. Gastroenterology Clinics of North America 16:1, pages 157-174.
Crossref
C Hendriksen, S Kreiner & V Binder. (1985) Long term prognosis in ulcerative colitis--based on results from a regional patient group from the county of Copenhagen.. Gut 26:2, pages 158-163.
Crossref
V Binder, C Hendriksen & S Kreiner. (1985) Prognosis in Crohn's disease--based on results from a regional patient group from the county of Copenhagen.. Gut 26:2, pages 146-150.
Crossref